The Paracor ventricular support system is a novel passive cardiomyoplasty device being evaluated for reducing wall stress in patients with dilated cardiomyopathy, with this paper focusing on its MRI evaluation.
Answers are grounded in this paper and cite their sources.
MRI assessment of Paracor support appears feasible in dilated cardiomyopathy; leaves open clinical efficacy pending randomized data.
A new passive cardiomyoplasty device, the Paracor ventricular support system (Paracor Medical Inc., Sunnyvale, California, USA) is being evaluated in heart failure patients to assess its ability to halt or reverse the disease process of dilated cardiomyopathy. During a minimal invasive surgical procedure the mesh is placed around the heart, and is intended to reduce wall stress by …
No takes yet. Share an insight, caveat, or question.
Grothues et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: